GSK PLC (LSE:GSK)
£ 13.81 0.01 (0.07%) Market Cap: 56.35 Bil Enterprise Value: 69.20 Bil PE Ratio: 22.64 PB Ratio: 4.02 GF Score: 69/100

GSK plc at Citi BioPharma Conference Transcript

Sep 07, 2022 / 05:50PM GMT
Release Date Price: £13.44 (-0.22%)
Andrew Simon Baum
Citigroup Inc., Research Division - Global Head of Healthcare Research and MD

Delighted to introduce our session. We have 2 key speakers from GSK. We have the President of Vaccines and Global Health Roger Connor and then secondly, we have Phil Dormitzer, who recently joined from Pfizer, who is, I'm going to say, head of R&D and Vaccines. correct? Got it. Okay. I have to make sure I get the terminology correct.

So look, I won't draw on the share price impact from the ongoing focus on nitrosamines and the concern over liability. But putting that aside, Vaccines has been an area which I know the company is feeling increasingly upbeat on. We're going to talk about the RSV update. We're going to talk about Shingrix, and then I want to spend some time talking about some of the next-generation vaccines that you have in your pipe.

Questions & Answers

Andrew Simon Baum
Citigroup Inc., Research Division - Global Head of Healthcare Research and MD

So maybe to kick off on Shingrix, could you update us as to the levels of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot